Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 409

1.

Staged urethroplasty: comparison of early functional results and quality of life in mesh graft and buccal mucosa technique.

Pfalzgraf D, Kluth L, Reiss P, Fisch M, Dahlem R.

Can J Urol. 2015 Apr;22(2):7720-6.

PMID:
25891336
2.

An updated prediction model of the global risk of cardiovascular disease in HIV-positive persons: The Data-collection on Adverse Effects of Anti-HIV Drugs (D:A:D) study.

Friis-Møller N, Ryom L, Smith C, Weber R, Reiss P, Dabis F, De Wit S, Monforte AD, Kirk O, Fontas E, Sabin C, Phillips A, Lundgren J, Law M; D:A:D study group.

Eur J Prev Cardiol. 2015 Apr 16. pii: 2047487315579291. [Epub ahead of print]

PMID:
25882821
3.

Development and validation of a risk score for chronic kidney disease in HIV infection using prospective cohort data from the D:A:D study.

Mocroft A, Lundgren JD, Ross M, Law M, Reiss P, Kirk O, Smith C, Wentworth D, Neuhaus J, Fux CA, Moranne O, Morlat P, Johnson MA, Ryom L; D:A:D study group; Royal Free Hospital Clinic Cohort; INSIGHT study group; SMART study group; ESPRIT study group.

PLoS Med. 2015 Mar 31;12(3):e1001809. doi: 10.1371/journal.pmed.1001809. eCollection 2015 Mar.

4.

Cancer risk and use of protease inhibitor or nonnucleoside reverse transcriptase inhibitor-based combination antiretroviral therapy: the D: A: D study.

Bruyand M, Ryom L, Shepherd L, Fatkenheuer G, Grulich A, Reiss P, de Wit S, D Arminio Monforte A, Furrer H, Pradier C, Lundgren J, Sabin C; D:A:D study group.

J Acquir Immune Defic Syndr. 2015 Apr 15;68(5):568-77. doi: 10.1097/QAI.0000000000000523.

PMID:
25763785
5.

Research in action: from AIDS to global health to impact. A symposium in recognition of the scientific contributions of Professor Joep Lange.

Boender TS, Barré-Sinoussi F, Cooper D, Goosby E, Hankins C, Heidenrijk M, de Jong M, Kazatchkine M, Laoye F, Merson M, Reiss P, Rinke de Wit TF, Rogo K, Schellekens O, Schultsz C, Sigaloff KC, Simon J, Zewdie D.

Antivir Ther. 2015;20(1):101-8. doi: 10.3851/IMP2946. Epub 2015 Feb 18. No abstract available.

PMID:
25691450
6.

Prospects of nanoscience with nanocrystals.

Kovalenko MV, Manna L, Cabot A, Hens Z, Talapin DV, Kagan CR, Klimov VI, Rogach AL, Reiss P, Milliron DJ, Guyot-Sionnnest P, Konstantatos G, Parak WJ, Hyeon T, Korgel BA, Murray CB, Heiss W.

ACS Nano. 2015 Feb 24;9(2):1012-57. doi: 10.1021/nn506223h. Epub 2015 Jan 22.

PMID:
25608730
7.

Risk of non-AIDS-defining events among HIV-infected patients not yet on antiretroviral therapy.

Zhang S, van Sighem A, Kesselring A, Gras L, Prins JM, Hassink E, Kauffmann R, Richter C, de Wolf F, Reiss P; ATHENA national observational HIV cohort study.

HIV Med. 2015 May;16(5):265-72. doi: 10.1111/hiv.12202. Epub 2015 Jan 21.

PMID:
25604160
8.

Diminished Impact of Ethnicity as a Risk Factor for Chronic Kidney Disease in the Current HIV Treatment Era.

Schoffelen AF, Smit C, van Lelyveld SF, Vogt L, Bauer MP, Reiss P, Hoepelman AI, Barth RE; on behalf of the ATHENA National Observational HIV Cohort.

J Infect Dis. 2015 Jan 18. pii: jiv026. [Epub ahead of print]

PMID:
25601941
9.

Enhanced charge separation in ternary P3HT/PCBM/CuInS2 nanocrystals hybrid solar cells.

Lefrançois A, Luszczynska B, Pepin-Donat B, Lombard C, Bouthinon B, Verilhac JM, Gromova M, Faure-Vincent J, Pouget S, Chandezon F, Sadki S, Reiss P.

Sci Rep. 2015 Jan 15;5:7768. doi: 10.1038/srep07768.

10.

Multivariate normative comparison, a novel method for more reliably detecting cognitive impairment in HIV infection.

Su T, Schouten J, Geurtsen GJ, Wit FW, Stolte IG, Prins M, Portegies P, Caan MW, Reiss P, Majoie CB, Schmand BA; AGEhIV Cohort Study Group.

AIDS. 2015 Mar 13;29(5):547-57. doi: 10.1097/QAD.0000000000000573.

PMID:
25587908
11.

Boosted lopinavir- versus boosted atazanavir-containing regimens and immunologic, virologic, and clinical outcomes: a prospective study of HIV-infected individuals in high-income countries.

HIV-CAUSAL Collaboration, Cain LE, Phillips A, Olson A, Sabin C, Jose S, Justice A, Tate J, Logan R, Robins JM, Sterne JA, van Sighem A, Reiss P, Young J, Fehr J, Touloumi G, Paparizos V, Esteve A, Casabona J, Monge S, Moreno S, Seng R, Meyer L, Pérez-Hoyos S, Muga R, Dabis F, Vandenhende MA, Abgrall S, Costagliola D, Hernán MA.

Clin Infect Dis. 2015 Apr 15;60(8):1262-8. doi: 10.1093/cid/ciu1167. Epub 2015 Jan 6.

PMID:
25567330
12.

Poorer cognitive performance in perinatally HIV-infected children versus healthy socioeconomically matched controls.

Cohen S, Ter Stege JA, Geurtsen GJ, Scherpbier HJ, Kuijpers TW, Reiss P, Schmand B, Pajkrt D.

Clin Infect Dis. 2015 Apr 1;60(7):1111-9. doi: 10.1093/cid/ciu1144. Epub 2014 Dec 16.

PMID:
25516183
13.

Internal urethrotomy in patients with recurrent urethral stricture after buccal mucosa graft urethroplasty.

Rosenbaum CM, Schmid M, Ludwig TA, Kluth LA, Reiss P, Dahlem R, Engel O, Chun FK, Riechardt S, Fisch M, Ahyai SA.

World J Urol. 2014 Nov 27. [Epub ahead of print]

PMID:
25428791
14.

Smoking and life expectancy among HIV-infected individuals on antiretroviral therapy in Europe and North America.

Helleberg M, May MT, Ingle SM, Dabis F, Reiss P, Fätkenheuer G, Costagliola D, d'Arminio A, Cavassini M, Smith C, Justice AC, Gill J, Sterne JA, Obel N.

AIDS. 2015 Jan 14;29(2):221-9. doi: 10.1097/QAD.0000000000000540.

15.

The prevalence and predictive value of dipstick urine protein in HIV-positive persons in Europe.

Mocroft A, Ryom L, Lapadula G, Reiss P, Blaxhult A, Furrer H, Kutsyna G, Gatell J, Begovac J, Kirk O, Lundgren J.

J Int AIDS Soc. 2014 Nov 2;17(4 Suppl 3):19561. doi: 10.7448/IAS.17.4.19561. eCollection 2014.

16.

Patients' willingness to take separate component antiretroviral therapy regimens for HIV in the Netherlands.

Engelhard E, Smith C, Vervoort S, Kroon F, Brinkman K, Nieuwkerk P, Reiss P, Geerlings S.

J Int AIDS Soc. 2014 Nov 2;17(4 Suppl 3):19536. doi: 10.7448/IAS.17.4.19536. eCollection 2014.

17.

Gender differences in HIV-positive persons in use of cardiovascular disease-related interventions: D:A:D study.

Hatleberg CI, Ryom L, El-Sadr W, Mocroft A, Reiss P, de Wit S, Dabis F, Pradier C, Monforte Ad, Rickenbach M, Law M, Lundgren J, Sabin C.

J Int AIDS Soc. 2014 Nov 2;17(4 Suppl 3):19516. doi: 10.7448/IAS.17.4.19516. eCollection 2014.

18.

A clinically useful risk-score for chronic kidney disease in HIV infection.

Mocroft A, Lundgren J, Ross M, Law M, Reiss P, Kirk O, Smith C, Wentworth D, Heuhaus J, Fux C, Moranne O, Morlat P, Johnson M, Ryom L; Data on Adverse Events (D:A:D) study group, the Royal Free Hospital Clinic Cohort and the INSIGHT study group.

J Int AIDS Soc. 2014 Nov 2;17(4 Suppl 3):19514. doi: 10.7448/IAS.17.4.19514. eCollection 2014.

19.

Lack of association between use of efavirenz and death from suicide: evidence from the D:A:D study.

Smith C, Ryom L, Monforte Ad, Reiss P, Mocroft A, El-Sadr W, Weber R, Law M, Sabin C, Lundgren J.

J Int AIDS Soc. 2014 Nov 2;17(4 Suppl 3):19512. doi: 10.7448/IAS.17.4.19512. eCollection 2014.

20.

Regional differences in self-reported HIV care and management in the EuroSIDA study.

Laut KG, Mocroft A, Lazarus J, Reiss P, Rockstroh J, Karpov I, Rakhmanova A, Knysz B, Moreno S, Gargalianos P, Lundgren J, Kirk O; Eurosida in Eurocoord.

J Int AIDS Soc. 2014 Nov 2;17(4 Suppl 3):19504. doi: 10.7448/IAS.17.4.19504. eCollection 2014.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk